#pharmaceutical_approval
Lupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution
MUMBAI, India, NAPLES, Fla, May 18, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the United States Food a…
Venus Remedies secures marketing nod in Argentina for antibiotic to treat bacterial infection
Venus Remedies gains marketing approval for Ceftriaxone in Argentina, enhancing its presence in Latin America's growing pharmaceutical market.